Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q4 2013 Earnings

8NovConfirmed

Feb 13

May 13

Q3 2013

Q4 2013

-0.2

-0.15

-0.09

-0.04

Details

Expected EPS

N/A

Actual EPS

-0.17

Surprise EPS

-0.17

Surprise Percent

+∞%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.17 per share for Q4 2013.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.